Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Booth

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
ERJ Open Research|December 24, 2025
Neutrophils in idiopathic pulmonary fibrosis patients are phenotypically distinct from controlsDeborah L W Chong, Jagdeep Sahota, Emma K Denneny, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2009
Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CTAshley M Groves, Thida Win, Nicholas J Screaton, et al.
The Journal of Infection|December 28, 2020
Improved treatment completion for tuberculosis patients: The case for a dedicated social care teamAbigail Izzard, Sue Wilders, Colette Smith, et al.
American Journal of Respiratory and Critical Care Medicine|July 15, 2006
Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosisMichael R Hill, Anastasia Papafili, Helen Booth, et al.
Clinical Epidemiology|January 10, 2022
Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE)Alejandro Arana, Anton Pottegård, Josephina G Kuiper, et al.
Eye (London, England)|August 8, 2019
Developing a pathway for the diagnosis and management of ocular tuberculosis. The pan-LOndon Ocular tuberculosis Pathway-LOOPHarry Petrushkin, Charanjit Sethi, Jessica Potter, et al.
Journal of Clinical Microbiology|June 1, 2018
Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture SequencingRonan M Doyle, Carrie Burgess, Rachel Williams, et al.
Pharmacoepidemiology and Drug Safety|October 16, 2024
Time Series Methods to Assess the Impact of Regulatory Action: A Study of UK Primary Care and Hospital Data on the Use of FluoroquinolonesYuchen Guo, Berta Raventós, Martí Català, et al.
The European Respiratory Journal|August 3, 2019
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidanceHelen R Stagg, Graham H Bothamley, Jennifer A Davidson, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
ERJ Open Research|December 24, 2025
Neutrophils in idiopathic pulmonary fibrosis patients are phenotypically distinct from controlsDeborah L W Chong, Jagdeep Sahota, Emma K Denneny, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2009
Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CTAshley M Groves, Thida Win, Nicholas J Screaton, et al.
The Journal of Infection|December 28, 2020
Improved treatment completion for tuberculosis patients: The case for a dedicated social care teamAbigail Izzard, Sue Wilders, Colette Smith, et al.
American Journal of Respiratory and Critical Care Medicine|July 15, 2006
Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosisMichael R Hill, Anastasia Papafili, Helen Booth, et al.
Clinical Epidemiology|January 10, 2022
Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE)Alejandro Arana, Anton Pottegård, Josephina G Kuiper, et al.
Eye (London, England)|August 8, 2019
Developing a pathway for the diagnosis and management of ocular tuberculosis. The pan-LOndon Ocular tuberculosis Pathway-LOOPHarry Petrushkin, Charanjit Sethi, Jessica Potter, et al.
Journal of Clinical Microbiology|June 1, 2018
Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture SequencingRonan M Doyle, Carrie Burgess, Rachel Williams, et al.
Pharmacoepidemiology and Drug Safety|October 16, 2024
Time Series Methods to Assess the Impact of Regulatory Action: A Study of UK Primary Care and Hospital Data on the Use of FluoroquinolonesYuchen Guo, Berta Raventós, Martí Català, et al.
The European Respiratory Journal|August 3, 2019
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidanceHelen R Stagg, Graham H Bothamley, Jennifer A Davidson, et al.
Pageof 3